Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Rainer

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Frontiers in Oncology|March 21, 2022
Eloquent Lower Grade Gliomas, a Highly Vulnerable Cohort: Assessment of Patients' Functional Outcome After Surgery Based on the LoG-Glio RegistryJan Coburger, Julia Onken, Stefan Rueckriegel, et al.
Cancers|November 11, 2022
Resilience in Lower Grade Glioma PatientsEllen Fröhlich, Claudia Sassenrath, Minou Nadji-Ohl, et al.
Journal of Neurological Surgery. Part A, Central European Neurosurgery|May 16, 2020
Erratum: Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio ProjectAndrej Pala, Minou Nadji-Ohl, Katharina Faust, et al.
Journal of Neurological Surgery. Part A, Central European Neurosurgery|September 25, 2019
Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio ProjectAndrej Pala, Minou Nadji-Ohl, Katharina Faust, et al.
Nature Communications|August 6, 2025
Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progressionLeo Carl Foerster, Oguzhan Kaya, Valentin Wüst, et al.
Nature Communications|October 17, 2025
Author Correction: Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progressionLeo Carl Foerster, Oguzhan Kaya, Valentin Wüst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2023
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical TrialConstantin Roder, Walter Stummer, Jan Coburger, et al.
Journal of Neuro-Oncology|October 15, 2025
Low tumour burden is associated with observation after surgery in patients with grade 2 astrocytoma and oligodendroglioma: results from the prospective multicentre LoG-Glio registryAndreas Ziebart, Julia Onken, Minou Nadji-Ohl, et al.
Neurological Research|October 8, 2022
Rationale and design of the peripheral nerve tumor registry: an observational cohort studyNora F Dengler, Christoph Scholz, Jürgen Beck, et al.
BMC Cancer|February 20, 2025
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastomaMatthias Schneider, Anna-Laura Potthoff, Yahya Ahmadipour, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Frontiers in Oncology|March 21, 2022
Eloquent Lower Grade Gliomas, a Highly Vulnerable Cohort: Assessment of Patients' Functional Outcome After Surgery Based on the LoG-Glio RegistryJan Coburger, Julia Onken, Stefan Rueckriegel, et al.
Cancers|November 11, 2022
Resilience in Lower Grade Glioma PatientsEllen Fröhlich, Claudia Sassenrath, Minou Nadji-Ohl, et al.
Journal of Neurological Surgery. Part A, Central European Neurosurgery|May 16, 2020
Erratum: Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio ProjectAndrej Pala, Minou Nadji-Ohl, Katharina Faust, et al.
Journal of Neurological Surgery. Part A, Central European Neurosurgery|September 25, 2019
Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio ProjectAndrej Pala, Minou Nadji-Ohl, Katharina Faust, et al.
Nature Communications|August 6, 2025
Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progressionLeo Carl Foerster, Oguzhan Kaya, Valentin Wüst, et al.
Nature Communications|October 17, 2025
Author Correction: Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progressionLeo Carl Foerster, Oguzhan Kaya, Valentin Wüst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2023
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical TrialConstantin Roder, Walter Stummer, Jan Coburger, et al.
Journal of Neuro-Oncology|October 15, 2025
Low tumour burden is associated with observation after surgery in patients with grade 2 astrocytoma and oligodendroglioma: results from the prospective multicentre LoG-Glio registryAndreas Ziebart, Julia Onken, Minou Nadji-Ohl, et al.
Neurological Research|October 8, 2022
Rationale and design of the peripheral nerve tumor registry: an observational cohort studyNora F Dengler, Christoph Scholz, Jürgen Beck, et al.
BMC Cancer|February 20, 2025
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastomaMatthias Schneider, Anna-Laura Potthoff, Yahya Ahmadipour, et al.
Pageof 16